Published in Epigenetics on August 09, 2012
The history of cancer epigenetics. Nat Rev Cancer (2004) 14.38
Genomic imprinting: parental influence on the genome. Nat Rev Genet (2001) 11.50
Epigenetics in human disease and prospects for epigenetic therapy. Nature (2004) 11.46
DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev (2005) 4.25
The Biomedical Resource Ontology (BRO) to enable resource discovery in clinical and translational research. J Biomed Inform (2010) 2.10
Epigenetics and human disease: translating basic biology into clinical applications. CMAJ (2006) 1.98
Epigenomics: genome-wide study of methylation phenomena. Curr Issues Mol Biol (2002) 1.93
MethyCancer: the database of human DNA methylation and cancer. Nucleic Acids Res (2007) 1.81
MethDB--a public database for DNA methylation data. Nucleic Acids Res (2001) 1.30
The imprinted gene and parent-of-origin effect database now includes parental origin of de novo mutations. Nucleic Acids Res (2006) 1.10
The MethDB DAS server: adding an epigenetic information layer to the human genome. Epigenetics (2006) 1.08
Computational micromodel for epigenetic mechanisms. PLoS One (2010) 0.81
Does a tree-like phylogeny only exist at the tips in the prokaryotes? Proc Biol Sci (2004) 2.05
A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins. PLoS Pathog (2011) 1.39
RNA-Seq vs dual- and single-channel microarray data: sensitivity analysis for differential expression and clustering. PLoS One (2012) 1.20
Evidence for heterogeneous selective pressures in the evolution of the env gene in different human immunodeficiency virus type 1 subtypes. J Virol (2005) 1.09
Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1. BMC Urol (2008) 1.08
Heterogeneous models place the root of the placental mammal phylogeny. Mol Biol Evol (2013) 1.05
Simultaneous miRNA and mRNA transcriptome profiling of human myoblasts reveals a novel set of myogenic differentiation-associated miRNAs and their target genes. BMC Genomics (2013) 1.04
Comparison of evolutionary algorithms in gene regulatory network model inference. BMC Bioinformatics (2010) 1.01
The Public Goods Hypothesis for the evolution of life on Earth. Biol Direct (2011) 0.96
Decreased bladder cancer growth in parous mice. Urology (2008) 0.94
Cross-platform microarray data normalisation for regulatory network inference. PLoS One (2010) 0.94
The phylogeny of the mammalian heme peroxidases and the evolution of their diverse functions. BMC Evol Biol (2008) 0.91
Interstitial cystitis antiproliferative factor (APF) as a cell-cycle modulator. BMC Urol (2004) 0.90
A pluralistic account of homology: adapting the models to the data. Mol Biol Evol (2013) 0.89
Fibroblast growth factor receptor-3 expression in meningiomas with stimulation of proliferation by the phosphoinositide 3 kinase-Akt pathway. J Neurosurg (2010) 0.86
Positive selection neighboring functionally essential sites and disease-implicated regions of mammalian reproductive proteins. BMC Evol Biol (2010) 0.85
Early detection and measurement of urothelial tumors in mice. Urology (2006) 0.85
Quantitative multi-agent models for simulating protein release from PLGA bioerodible nano- and microspheres. J Pharm Biomed Anal (2008) 0.84
A case-by-case evolutionary analysis of four imprinted retrogenes. Evolution (2011) 0.83
Functional consequence of positive selection revealed through rational mutagenesis of human myeloperoxidase. Mol Biol Evol (2012) 0.83
Response to Teladorsagia circumcincta infection in Scottish Blackface lambs with divergent phenotypes for nematode resistance. Vet Parasitol (2014) 0.82
Cell type-dependent, infection-induced, aberrant DNA methylation in gastric cancer. J Theor Biol (2010) 0.82
Computational micromodel for epigenetic mechanisms. PLoS One (2010) 0.81
Colon cancer associated genes exhibit signatures of positive selection at functionally significant positions. BMC Evol Biol (2012) 0.80
Analysis of transforming growth factor β receptor expression and signaling in higher grade meningiomas. J Neurooncol (2010) 0.79
Bone morphogenetic protein 4 and its receptors are expressed in the leptomeninges and meningiomas and signal via the Smad pathway. J Neuropathol Exp Neurol (2009) 0.78
Cucurbitacin I blocks cerebrospinal fluid and platelet derived growth factor-BB stimulation of leptomeningeal and meningioma DNA synthesis. BMC Complement Altern Med (2013) 0.78
Grade progression and regression in recurrent urothelial cancer. J Urol (2003) 0.78
Consensus mutagenesis reveals that non-helical regions influence thermal stability of horseradish peroxidase. Biochimie (2008) 0.77
Mesothelin expression in the leptomeninges and meningiomas. J Histochem Cytochem (2008) 0.77
Integrating heterogeneous gene expression data for gene regulatory network modelling. Theory Biosci (2011) 0.77
Molecular adaptation of telomere associated genes in mammals. BMC Evol Biol (2013) 0.76
Model refinement through high-performance computing: an agent-based HIV example. Immunome Res (2010) 0.75
A computational model for genetic and epigenetic signals in colon cancer. Interdiscip Sci (2013) 0.75
Differential expression of somatostatin receptors, P44/42 MAPK, and mTOR activation in medulloblastomas and primitive neuroectodermal tumors. Appl Immunohistochem Mol Morphol (2013) 0.75
Mitochondrial data are not suitable for resolving placental mammal phylogeny. Mamm Genome (2014) 0.75
3D Multi-agent models for protein release from PLGA spherical particles with complex inner morphologies. Theory Biosci (2008) 0.75
Diversity emergence and dynamics during primary immune response: a shape space, physical space model. Theory Biosci (2004) 0.75
Computational Models & Methods in Systems Biology & Medicine. IET Syst Biol (2015) 0.75